Literature DB >> 15760647

Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage.

Jin-Moo Lee1, Kejie Yin, Idar Hsin, Shawei Chen, John D Fryer, David M Holtzman, Chung Y Hsu, Jian Xu.   

Abstract

Spontaneous intracerebral hemorrhage (ICH) is one of the most recognized complications of cerebral amyloid angiopathy (CAA), but little is known about the molecular pathogenesis of this life-threatening complication. In this review, we present preliminary evidence which suggests that the extracellular-matrix-degrading protease, matrix metalloproteinase-9 (MMP-9), may play a role in the development of spontaneous ICH resulting from CAA. The amyloid-beta peptide (Abeta) induced the synthesis, cellular release, and activation of MMP-9 in murine cerebral endothelial cells (CECs), resulting in increased extracellular matrix (ECM) degradation. Furthermore, in a mouse model of CAA (APPsw transgenic mice), MMP-9 immunoreactivity was observed in amyloid-laden cerebral vessels in aged APPsw mice but not in young APPsw or aged wild-type mice. More extensive MMP-9 immunostaining was present in amyloid-laden vessels with evidence of microhemorrhage. These results suggest that increased vascular MMP-9 expression, stimulated by Abeta, may play a role in the pathogenesis of spontaneous intracerebral hemorrhage (ICH) in patients with CAA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760647     DOI: 10.1016/j.jns.2004.11.041

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  25 in total

1.  Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.

Authors:  Anika M S Hartz; Björn Bauer; Emma L B Soldner; Andrea Wolf; Sandra Boy; Roland Backhaus; Ivan Mihaljevic; Ulrich Bogdahn; Hans H Klünemann; Gerhard Schuierer; Felix Schlachetzki
Journal:  Stroke       Date:  2011-11-23       Impact factor: 7.914

2.  Recurrence of Lobar Hemorrhage: A Red Flag for Cerebral Amyloid Angiopathy-related Inflammation?

Authors:  Vaibhav Rastogi; Lauren L Donnangelo; Ganesh Asaithambi; Sharatchandra Bidari; Anna Y Khanna; Vishnumurthy Shushrutha Hedna
Journal:  Innov Clin Neurosci       Date:  2015 May-Jun

3.  Abnormal post-translational and extracellular processing of brevican in plaque-bearing mice over-expressing APPsw.

Authors:  Joanne M Ajmo; Lauren A Bailey; Matthew D Howell; Lisa K Cortez; Keith R Pennypacker; Hina N Mehta; Dave Morgan; Marcia N Gordon; Paul E Gottschall
Journal:  J Neurochem       Date:  2010-02-17       Impact factor: 5.372

Review 4.  Cerebral microhemorrhages: mechanisms, consequences, and prevention.

Authors:  Zoltan Ungvari; Stefano Tarantini; Angelia C Kirkpatrick; Anna Csiszar; Calin I Prodan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

5.  A possible molecular mechanism of hearing loss during cerebral ischemia in mice.

Authors:  Pradip Kumar Kamat; Anuradha Kalani; Naira Metreveli; Suresh C Tyagi; Neetu Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2015-03-11       Impact factor: 2.273

Review 6.  The influence of the amyloid ß-protein and its precursor in modulating cerebral hemostasis.

Authors:  William E Van Nostrand
Journal:  Biochim Biophys Acta       Date:  2015-10-27

7.  Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells.

Authors:  Mar Hernandez-Guillamon; Stephanie Mawhirt; Silvia Fossati; Steven Blais; Mireia Pares; Anna Penalba; Merce Boada; Pierre-Olivier Couraud; Thomas A Neubert; Joan Montaner; Jorge Ghiso; Agueda Rostagno
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

8.  Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier.

Authors:  Ben Shackleton; Charis Ringland; Laila Abdullah; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Mol Neurobiol       Date:  2019-06-18       Impact factor: 5.590

9.  Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.

Authors:  Mar Hernandez-Guillamon; Stephanie Mawhirt; Steven Blais; Joan Montaner; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  J Biol Chem       Date:  2015-04-20       Impact factor: 5.157

10.  Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.

Authors:  Monica Garcia-Alloza; Claudia Prada; Carli Lattarulo; Sara Fine; Laura A Borrelli; Rebecca Betensky; Steven M Greenberg; Matthew P Frosch; Brian J Bacskai
Journal:  J Neurochem       Date:  2009-04-08       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.